Investors need to do serious research to find the answers to many developments now occurring in the cannabis industry.
If you are an investor, entrepreneur, manufacturer or retailer, the national legalization of hemp and CBD has opened a world of opportunities – each with their own questions: “What is the impact of mass market retailers entering the market? How are businesses navigating regulatory gray areas? What are the obstacles and opportunities across the hemp & CBD supply chain? How are new processing techniques based on the molecular mapping of the cannabis molecule affecting the industry? Yes, the cannabis molecule has been mapped, and new elements have been discovered. What does this mean for investors? Can you even imagine a new treatment for cancer or for that matter even a cure?
I suggest research can now be done without the need to actually have cannabis in the laboratory. Furthermore, orphan drugs may now be developed that the FDA otherwise may not have approved. With individual elements now mapped, will THC in its molecular form even be necessary?
Lots going on that most do not know, and the impact of this technology is yet to be discovered by most investors. Perhaps investors should stop their speculation of riches and actually research how new discoveries could affect their investments.
Kgem
If you are an investor, entrepreneur, manufacturer or retailer, the national legalization of hemp and CBD has opened a world of opportunities – each with their own questions: “What is the impact of mass market retailers entering the market? How are businesses navigating regulatory gray areas? What are the obstacles and opportunities across the hemp & CBD supply chain? How are new processing techniques based on the molecular mapping of the cannabis molecule affecting the industry? Yes, the cannabis molecule has been mapped, and new elements have been discovered. What does this mean for investors? Can you even imagine a new treatment for cancer or for that matter even a cure?
I suggest research can now be done without the need to actually have cannabis in the laboratory. Furthermore, orphan drugs may now be developed that the FDA otherwise may not have approved. With individual elements now mapped, will THC in its molecular form even be necessary?
Lots going on that most do not know, and the impact of this technology is yet to be discovered by most investors. Perhaps investors should stop their speculation of riches and actually research how new discoveries could affect their investments.
Kgem
1
